EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Е-cadherin expression in invasive ductal breast cancer

Ilona V Chelpanova, Liliya I Volos, Andrii P Dudash, Yevgen V Paltov, Artur V Poliiants, Olha V Dudok, Yulia V Hnidyk

Wiadomości Lekarskie · 27.02.2026 · (2) · 255-264

DOI: 10.36740/wlek/218713 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wiadomości Lekarskie, online erschienen am 27.02.2026. Verfasst von Ilona V Chelpanova und 6 weiteren Autor:innen. Beteiligte Einrichtung: STATE NON-PROFIT ENTERPRISE «DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY», LVIV, UKRAINE. Hauptthemen laut MEDLINE: Cadherins, Breast Neoplasms, Carcinoma, Ductal, Breast.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate E-cadherin expression in various clinical and pathological prognostic scenarios to determine its significance in the development of molecular subtypes of invasive ductal breast cancer. Materials and Methods: A comprehensive morphological and immunohistochemical study of 80 cases of invasive ductal carcinoma (IDC) was conducted to determine the molecular phenotype. The expression of E-cadherin, ER, PR receptors, c-erbB2, and Ki-67 was evaluated according to the manufacturer’s standardized protocols using appropriate positive and negative controls. The degree of tumor malignancy was determined using the modified Scarff-Bloom- Richardson system. Semi-quantitative assessment of E-cadherin expression was performed using the Qureshi scale. Pearson’s criterion was used for statistical analysis. Differences were considered statistically significant at p < 0.05.

Results

Low E-cadherin expression was associated with stage 3, pT3, and G2/G3 grades of IDBC malignancy, confirming its unfavorable prognostic significanc and correlation with the molecular profile. High E-cadherin expression was characteristic of ER-positive luminal A tumors, regardless of menopause, indicating a regulatory role for ER expression. The low proliferative activity of luminal IDBC cells was explained by high E-cadherin expression, which increased adhesive properties. Low E-cadherin expression is also a prognostic marker for TNBC.

Conclusions

E-cadherin is a potent tumor suppressor in breast cancer. Its role in disease progression is confirmed by the correlation between partial or complete loss of E-cadherin expression and poor prognosis for patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CadherinsBreast NeoplasmsCarcinoma, Ductal, BreastHumansFemaleMiddle AgedBiomarkers, TumorPrognosisReceptors, EstrogenAdultErb-b2 Receptor Tyrosine KinasesAntigens, CDReceptors, Progesterone

Stichwörter der Autor:innen

E-cadherin expressioninvasive ductal breast cancermolecular phenotypemorphological and immunohistochemical study

Substanzen

CadherinsBiomarkers, TumorReceptors, EstrogenErb-b2 Receptor Tyrosine KinasesAntigens, CDReceptors, Progesterone

Autor:innen und Institutionen

  • STATE NON-PROFIT ENTERPRISE «DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY», LVIV, UKRAINE.
  • WESTERN UKRAINIAN HISTOLOGICAL LABORATORY, LVIV, UKRAINE.
  • INTERNATIONAL MEDICAL CENTER LLC, KYIV, UKRAINE.

Zitieren

APA

Chelpanova, I. V., Volos, L. I., Dudash, A. P., Paltov, Y. V., Poliiants, A. V., Dudok, O. V., & Hnidyk, Y. V. (2026). Evaluation of Е-cadherin expression in invasive ductal breast cancer. Wiadomości Lekarskie, 255-264. https://doi.org/10.36740/wlek/218713

Vancouver

Chelpanova IV, Volos LI, Dudash AP, Paltov YV, Poliiants AV, Dudok OV, et al. Evaluation of Е-cadherin expression in invasive ductal breast cancer. Wiadomości Lekarskie. 2026:255-264. doi:10.36740/wlek/218713

BibTeX
@article{Chelpanova2026,
  author = {Chelpanova, Ilona V and Volos, Liliya I and Dudash, Andrii P and Paltov, Yevgen V and Poliiants, Artur V and Dudok, Olha V and Hnidyk, Yulia V},
  title = {Evaluation of Е-cadherin expression in invasive ductal breast cancer},
  journal = {Wiadomości Lekarskie},
  year = {2026},
  number = {2},
  pages = {255--264},
  doi = {10.36740/wlek/218713}
}
Kostenlos starten →